Nifty futures have been trading 46.55 points or .31 per cent down at 14,828 on Singaporean Exchange, suggesting a damaging opening for BSE Sensex and Nifty 50. In prior session, due to weak worldwide industry cues, Nifty and Sensex witnessed promoting stress, and shed more than 90 points and 340 points, respectively. According to an analyst, post sturdy uptrend rally, bulls might choose to take a short-term pause close to 14950/ 49500 and simply because of weak worldwide industry situations industry probably to consolidate amongst 14750 to 14900/ 48500-49300 price tag variety. “For the day traders, 14900/49300 would be the key level to watch out, above the same we can expect continuation of uptrend wave up to 14965-15000/ 49800-50000,” stated Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities.
Stocks to watch today:
RIL, Airtel, Voda-Idea: Telecom stocks such as Reliance Industries Ltd, Bharti Airtel, Vodafone Idea will stay in concentrate today. India’s biggest telecom operator Reliance Jio added 4.26 million wireless clients followed by 3.73 million by Bharti Airtel. While Vodafone Idea managed to add 652,625 subscribers in February, according to the Telecom Regulatory Authority of India (Trai).
Yes Bank: Bay Tree India Holdings, owned by Tilden Park, lowered its stake in Yes Bank by 2.08%, representing practically a third of its holding in the lender. According to regulatory filings, Bay Tree now holds a 5.4% stake in Yes Bank.
Asian Paints, Pidilite Industries: Lupin, Jindal Steel & Power, UPL Ltd, Asian Paints, Pidilite Industries, Tata Power Company, Voltas, Apollo Tyres, Happiest Minds Technologies, Mahindra Lifespace Developers, HG Infra Engineering, Sagar Cements, and Birla Corporation are some of the businesses that will report their quarterly benefits today.
Infosys: Infosys announced that it has been chosen by Britvic, one of the major branded
soft drinks companies in Europe, as a strategic finish-to-finish companion to assistance them provide their strategic
transformation roadmap and operations, across Applications, Cloud Infrastructure, Service Management and End User Computing.
Dr Reddy’s Laboratories: Dr. Reddy’s Laboratories Ltd, along with its subsidiaries with each other referred to as announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial authorized by the U.S. Food and Drug Administration (USFDA).
Siemens: Siemens reported a consolidated profit at Rs 334.4 crore in Q2FY21 against Rs 175.7 crore in Q2FY20, income improved to Rs 3,483.7 crore from Rs 2,640.2 crore-on year.